Financial Daily from THE HINDU group of publications
Saturday, May 20, 2006


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Awards & Honours


Indegene wins Global Pyramid Award

Our Bureau

New Delhi, May 19

Indegene, provider of medical and scientific marketing services to the pharmaceutical industry partnered with GlaxoSmithKline Consumer Healthcare (GSKCH), India, to win the Global Pyramid Award for excellence in medical marketing in the category "Best Use of Science". Indegene's efforts to build scientific awareness for the `Horlicks Clinically Proven' campaign helped to win this year's award. The campaign was based on the large clinical which proved that Horlicks supplementation to school children improved their nutritional status. Indegene helped GSKCH formulate the scientific communication material, develop a scientific advisory board and generate substantial local data for the initiative.

More Stories on : Awards & Honours | Healthcare Products

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
GAIL begins naphtha marketing


GAIL commissions UP pipeline
Birla-Lodha tussle: Calcutta HC appoints four administrators
IFC package for LG Balakrishnan
Prajay Engg converts FCCBs
Indegene wins Global Pyramid Award
Seeds of litigation
Ashok Narain floats HR firm
Aban Loyd to buy 52 pc in Indonesian co
Praj Industries on the prowl
CII welcomes amendments to Cos Act
Global Hospitals, BioGenex ink deal
Unichem ties up with Pliva for US market
Radico Khaitan enters into ventures in UK, Africa
`Engineering is on a stronger growth path than sugar'
Yamaha targets higher sales in TN, Kerala
Orchid targets 30 pc topline growth
Ford upbeat on mid-size sedans
New Finance Director for MRPL



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | Business Line | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2006, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line